Delayed culture conversion predicts poor outcomes for isoniazid mono-resistant TB in Uganda: a retrospective cross-sectional study from 2017– 2022

Delayed culture conversion predicts poor outcomes for isoniazid mono-resistant TB in Uganda: a retrospective cross-sectional study from 2017– 2022

Abstract Background Isoniazid-resistant, Rifampicin-susceptible Tuberculosis (TB) is estimated to occur in 13% of new cases and 17% of previously treated cases. Current WHO guidelines recommend treatment with Rifampicin (RFP), ethambutol (EMB, E), pyrazinamide (PZA, Z), and levofloxacin (LFX, Q) for...

Full description

Saved in:
Bibliographic Details
Main Authors: Joel Kabugo, Obondo James Sande, Jupiter Marina Kabahita, Joanita Namutebi, Dennis Mujuni, Hellen Rosette Oundo, Daniel Kisakye, Dorothy Nassozi Batte, Moses Joloba, Gerald Mboowa
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Infectious Diseases
Subjects:
Culture conversion
Isoniazid mono-resistant
Mycobacterium tuberculosis
Treatment outcomes
Uganda
Online Access:https://doi.org/10.1186/s12879-025-11218-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12879-025-11218-5

Similar Items